Home » Topics » Regulatory

Regulatory
RSS

CE Mark for Aspirair drug powder inhaler

Jan. 29, 2007

Inovelon approved in E.U. for Lennox-Gastaut syndrome

Jan. 22, 2007

New European approval for Keppra

Jan. 17, 2007

FDA approves Lialda in ulcerative colitis

Jan. 17, 2007

Neupro now approved in Europe for all stages of Parkinson's disease

Jan. 17, 2007

Mycamine launched in 100 mg vial format

Jan. 16, 2007

Swedish MPA approves Cipralex in OCD

Jan. 15, 2007

Invega approved for treatment of schizophrenia

Dec. 22, 2006

FDA approval for Invanz

Dec. 22, 2006

Pediatric indication approved for Colazal

Dec. 22, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.